RecruitingNot ApplicableNCT06879457

mHealth Person-centred Self-care Support for Homebound Older Adults: A Hybrid Effectiveness-implementation Study

Empowering Homebound Older Adults in Self-care Using a Mobile Health-assisted, Person-centred Care Approach: A Hybrid Effectiveness-implementation Design


Sponsor

The Hong Kong Polytechnic University

Enrollment

130 participants

Start Date

Mar 10, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of the study is to evaluate the effectiveness and implementation of the mobile health (mHealth)-assisted, person-centred care (PCC) self-care support programme for homebound older adults. The researcher will compare PCC approach to a conventional care provider-led model. Participants (n = 130) will receive the intervention of six bi-weekly WhatsApp video call sessions over three months with nurse case managers (NCMs).


Eligibility

Min Age: 60 Years

Inclusion Criteria6

  • Aged 60 years or older;
  • Unable to leave home more than twice per week due to physical or functional health problems;
  • Own and have basic proficiency in using a smartphone;
  • Speak Cantonese;
  • Indicate sufficient cognitive ability; and
  • Be moderately frail or below.

Exclusion Criteria3

  • Unable to hear, see, or communicate effectively;
  • Be completely bed-bound; or
  • Reside in an area without stable internet coverage.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALPCC-based mHealth-assisted self-care support intervention

Participants receive six bi-weekly WhatsApp video call sessions with a NCM over three months, using a person-centred care (PCC) approach.

BEHAVIORALProvider-led mHealth-assisted self-care support intervention

Participants receive six bi-weekly WhatsApp video call sessions with a NCM over three months, based on the conventional provider-led model.


Locations(1)

Yan Oi Tong

Hong Kong, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06879457


Related Trials